Finally, we detected an increased expression of calreticulin and secretion of HMGB1 (ref. 33), two markers related to immunogenic cell death, in ALL, AML and DLBCL cells 48 h after CM-272 treatment (Fig. 3e,f). The gene discussed is CALR; the disease is acute myeloid leukemia.